Literature DB >> 7869210

Inhaled nitric oxide for premature infants after prolonged rupture of the membranes.

A Peliowski1, N N Finer, P C Etches, A J Tierney, C A Ryan.   

Abstract

We evaluated the use of inhaled nitric oxide in eight premature infants (520 to 1440 gm, 24 to 31 weeks of gestation) who failed to respond to conventional management and who had prolonged rupture of the membranes and oligohydramnios. All infants had a significant improvement in oxygenation and a fall in mean airway pressure with inhaled nitric oxide. Further studies are required to determine the safety and efficacy of this form of therapy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7869210     DOI： 10.1016/s0022-3476(95)70467-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Response to inhaled nitric oxide in premature and term neonates.

Authors:  T Hoehn; M F Krause
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Inhaled nitric oxide in neonates.

Authors:  N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

3.  Response to inhalative nitric oxide in a severely acidotic preterm newborn with lung hypoplasia.

Authors:  M Wallot; B Wulff; L Hanssler; T Voit
Journal:  Eur J Pediatr       Date:  1996-12       Impact factor: 3.183

4.  Inhaled nitric oxide in preterm infants with prolonged preterm rupture of the membranes: a case series.

Authors:  J Semberova; S M O'Donnell; J Franta; J Miletin
Journal:  J Perinatol       Date:  2015-04       Impact factor: 2.521

5.  Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide.

Authors:  N V Subhedar; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

6.  Inhaled nitric oxide use in newborns.

Authors:  Abraham Peliowski
Journal:  Paediatr Child Health       Date:  2012-02       Impact factor: 2.253

Review 7.  Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant.

Authors:  Gregory M Sokol; Girija G Konduri; Krisa P Van Meurs
Journal:  Semin Perinatol       Date:  2016-10       Impact factor: 3.300

8.  Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.

Authors:  Monika M Gadhia; Gary R Cutter; Steven H Abman; John P Kinsella
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

9.  Association of Early Inhaled Nitric Oxide With the Survival of Preterm Neonates With Pulmonary Hypoplasia.

Authors:  Kevin R Ellsworth; Marc A Ellsworth; Amy L Weaver; Kristin C Mara; Reese H Clark; William A Carey
Journal:  JAMA Pediatr       Date:  2018-07-02       Impact factor: 16.193

10.  Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?

Authors:  Praveen Chandrasekharan; Rafal Kozielski; Vasantha H S Kumar; Munmun Rawat; Veena Manja; Changxing Ma; Satyan Lakshminrusimha
Journal:  Am J Perinatol       Date:  2016-09-14       Impact factor: 1.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.